Cargando…
Efficacy and safety of hypoglycemic drugs in improving cognitive function in patients with Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis
OBJECTIVE: The purpose of this study was to compare the effects of oral hypoglycaemic drugs (HDs) on cognitive function and biomarkers of mild cognitive impairment (MCI) and Alzheimer's disease (AD) through a network meta-analysis of randomized controlled trials (RCTs). METHODS: We conducted sy...
Autores principales: | Wang, Xin-Chen, Chu, Chen-Liang, Li, Han-Cheng, Lu, Kuan, Liu, Cheng-Jiang, Cai, Ye-Feng, Quan, Shi-Jian, Zhang, Shi-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747761/ https://www.ncbi.nlm.nih.gov/pubmed/36530613 http://dx.doi.org/10.3389/fneur.2022.1018027 |
Ejemplares similares
-
The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment
por: Weng, Wei-Chieh, et al.
Publicado: (2019) -
Olfactory memory in mild cognitive impairment and Alzheimer’s disease
por: Audronyte, Egle, et al.
Publicado: (2023) -
Transcranial magnetic stimulation effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis
por: Yan, Yixin, et al.
Publicado: (2023) -
Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023) -
The Clinical Course of Early and Late Mild Cognitive Impairment
por: Lin, Szu-Ying, et al.
Publicado: (2022)